Cheap Stocks Poised for Rebound, Analysts Suggest

By Bill Bullington

ᐧ

3/6, 13:34 EST

GlaxoSmithKline (GSK) stands out with a 15% year-to-date performance, the highest among the listed "cheap" stock picks, and is currently trading below its analyst target price of $45.29.
Freeport-McMoRan (FCX) has experienced a notable decline, with a -12.80% year-to-date performance, yet it still holds an analyst target price of $46.17, suggesting potential upside according to FactSet analysts.